E. Anders Kolb: LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group

E. Anders Kolb, President and CEO at The Leukemia and Lymphoma Society, recently posted on LinkedIn:

“As an early funder of research that led to the development of CAR-T cell therapy, The Leukemia & Lymphoma Society has longstanding expertise and commitment to immune-based therapies for treating blood cancers. LLS’s Chief Medical Officer Gwen Nichols recently addressed what patients need to know about CAR-T and what questions remain in her interview with CURE Media Group.”

View additional information.
Source: E. Anders Kolb/LinledIn